July 21, 2025 a 03:43 pm
MRK: Fundamental Ratio Analysis - Merck & Co., Inc.
Merck & Co., Inc. is a prominent player in the healthcare sector, offering a diverse range of pharmaceutical products globally. With strong collaborations and innovative solutions in both human and animal health, the company sustains a robust market position. As of now, its stock demonstrates a stable outlook, underscored by promising analyst evaluations and steady financial performance.
Fundamental Rating
Merck & Co., Inc. holds a strong position in the market with an overall rating of A-. The company shows impressive returns across several metrics, however, there's room for improvement in its debt to equity ratio.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 3 | |
| Price to Book | 2 |
Historical Rating
Historical data indicates a stable performance over time, with consistent scores across various evaluation criteria.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-18 | 4 | 5 | 5 | 5 | 1 | 3 | 2 |
| N/A | 0 | 5 | 5 | 5 | 1 | 3 | 2 |
Analyst Price Targets
Analyst estimates reveal a positive outlook for MRK with a consensus price target aligning with the median value, suggesting a stable expected performance.
| High | Low | Median | Consensus |
|---|---|---|---|
| 98 | 82 | 90 | 90 |
Analyst Sentiment
Analyst recommendations predominantly lean towards 'Buy', reflecting overall confidence in the company's future performance.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 25 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Merck & Co., Inc. offers a promising investment opportunity, driven by its strong market positioning and robust financial metrics. While the debt to equity ratio remains a concern, the consistent high scores in other areas underscore the company's potential for stable returns. Analyst confidence further supports a favorable outlook for the stock. However, investors should remain cautious of market volatility and evaluate the company's strategic initiatives to maintain competitiveness.